Yanqing Ding

Yanqing Ding

Auto-generated profile, based on publicly available information

Yanqing Ding

Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2011 in Cell Research
Verified
Journal Article
Closed access
WZWei-Jie Zhou
Wei-Jie Zhou
ZGZhen H Geng
Zhen H Geng
SCShan Chi
Shan Chi
WZWenli Zhang
Wenli Zhang
XNXiao-Feng Niu
Xiao-Feng Niu
JGJian-Guo Geng
Jian-Guo Geng

8 September 2014 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
LXLijun Xu
Lijun Xu
YZYue Zhang
Yue Zhang
HWHui Wang
Hui Wang
GZGuanhua Zhang
Guanhua Zhang
YDYanqing Ding
Yanqing Ding
LZLiang Zhao
Liang Zhao
Aberrant expression of miR-1 has been implicated in various cancers. However, the mechanisms underlying the role of miR-1 in CRC progression still have not been clarified clearly. Here, we showed the decreased expression of miR-1 in colorectal carcinoma (CRC) tissues and cell lines. Ectopic introduction of miR-1 suppressed cell proliferation and migration, whereas miR-1 inhibitor performed contrary functions in CRC cells. Stable overexpression of miR-1 was sufficient to inhibit tumor growth and homing capacity in vivo. Proteomic analysis revealed that miR-1 modulated the expression of key cellular molecules and involved in the MAPK and PI3K/AKT pathways by inhibiting phosphorylation of ERK and AKT. Meanwhile, miR-1 also reversed epithelial–mesenchymal transition (EMT), which played a pivotal role in the initiation of metastasis. Further studies found that miR-1 can target the 3' untranslated region (3'UTR) of LIM and SH3 protein 1 (LASP1) mRNA and suppress the expression of LASP1, identified as a CRC-associated protein. In contrast to the phenotypes induced by miR-1 restoration, LASP1-induced cell proliferation and migration partly rescued miR-1-mediated biological behaviors. Our results illustrated that miR-1 play a critical role in CRC progression, which suggests its potential role in the molecular therapy of cancer.

12 June 2017 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
BWBin Wang
Bin Wang
LZLanzhi Zhang
Lanzhi Zhang
LZLiying Zhao
Liying Zhao
RZRui Zhou
Rui Zhou
YDYanqing Ding
Yanqing Ding
LZLiang Zhao
Liang Zhao
LASP2 (LIM and SH3 Protein 2) is a small focal adhesion protein belongs to nebulin protein family. As the newest member of nebulette family, the function of LASP2 remains to be identified. The relationship between LASP2 expression and clinical characteristics of CRC was analyzed in 89 paraffin-embedded archived CRC specimens by immunohistochemistry (IHC). The effects of LASP2 on cell growth and migration were examined in vitro, using CCK-8 and transwell assays. Western blotting was performed to examine the impact of LASP2 on the SAPK/JNK and MAPK signaling pathways. In the present study, we observed a decreased LASP2 expression in clinical colorectal cancer samples compared with paired normal tissues. A negative correlation was also found between LASP2 and poor prognosis of CRC patients. Gain- and loss-of-function approaches revealed that LASP2 plays inhibitory effects on the growth and migration of human CRC cells in vitro. Western-blot results showed that LASP2 could attenuate epithelial-mesenchymal transition (EMT) to accomplish its suppression on CRC aggression. In LASP2 knocked down CRC cells, EMT was inhibited along with the inactivation of JNK/p38 MAPK pathway. Consistently, treatment of JNK inhibitor (JNK inhibitor II) together with p38 inhibitor (SB203580) could resume the process of EMT. Interestingly, we found a negative relationship between LASP2 and LASP1 expression in both CRC cell lines and tumors tissues, which suggests their converse function in CRC progression. All the findings indicated that LASP2 may play a significant role in suppressing CRC progression and provided a novel biomarker for CRC therapy.

31 August 2010 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
LZLiang Zhao
Liang Zhao
HWHui Wang
Hui Wang
XSXuegang Sun
Xuegang Sun
YDYanqing Ding
Yanqing Ding

9 May 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZSZiyun Shao
Ziyun Shao
YCYanjun Cai
Yanjun Cai
LXLijun Xu
Lijun Xu
XYXueqing Yao
Xueqing Yao
JSJiaolong Shi
Jiaolong Shi
LZLiang Zhao
Liang Zhao
LIM and SH3 protein 1 (LASP1) can promote colorectal cancer (CRC) progression and metastasis, but the direct evidence that elucidates the molecular mechanism remains unclear. Here, our proteomic data showed that LASP1 interacted with 14-3-3σ and decreased the expression of 14-3-3σ in CRC. Deletion of 14-3-3σ was required for LASP1-mediated CRC cell aggressiveness. In vitro gain- and loss-of-function assays showed that 14-3-3σ suppressed the ability of cell migration and decreased the phosphorylation of AKT in CRC cells. We further observed clearly co-localization between AKT and 14-3-3σ in CRC cells. Treatment of PI3K inhibitor LY294002 markedly prevented phosphorylation of AKT and subsequently counteract aggressive phenotype mediated by siRNA of 14-3-3σ. Clinically, 14-3-3σ is frequently down-regulated in CRC tissues. Down-regulation of 14-3-3σ is associated with tumor progression and poor prognosis of patients with CRC. Multivariate analysis confirmed low expression of 14-3-3σ as an independent prognostic factor for CRC. A combination of low 14-3-3σ and high LASP1 expression shows a worse trend with overall survival of CRC patients. Our research paves the path to future investigation of the LASP1-14-3-3σ axis as a target for novel anticancer therapies of advanced CRC.

12 November 2010 in Journal of Comparative Pathology
Verified
Journal Article
Closed access
LZL. Zhao
L. Zhao
YLY. Liu
Y. Liu
XSX. Sun
X. Sun
KPK. Peng
K. Peng
YDY. Ding
Y. Ding